The Pathogenesis of Fibromyalgia Syndrome: An Update

REFERENCES

• Cohen ML. Is fibromyalgia a distinct clinical entity? The disapproving rheumatologist's evidence. Baillière's Best Pract Res Clin Rheumatol 1999;13:421–5
   Google Scholar
• Wolfe F, Ross K, Anderson J, Russell IJ, Herbert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38:19–28
   PubMed Web of Science ®Google Scholar
• Ehrlich GE. Pain is real; fibromyalgia isn't. J Rheumatol 2003; 30:1666–7
   PubMed Web of Science ®Google Scholar
• Hadler NM. 'Fibromyalgia' and the medicalisation of misery. J Rheumatol 2003;30:1668–9
   Google Scholar
• White KP, Thomson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 2003; 30:1835–40
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multi-centre criteria committee Arthritis Rheum 1990;33:160–72
   Google Scholar
• Wolfe F. The relationship between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997; 56:268–71
   PubMed Web of Science ®Google Scholar
• Fitzcharles M-A. Is fibromyalgia a distinct clinical entity? The approving rheumatologist's evidence. Baillière's Clin Rheumatol 1999;13:437–43
   Google Scholar
• Croft P. Testing for tenderness: what's the point? J Rheumatol 2000;27:2531–2
   Google Scholar
• Wolfe F, Ross K, Anderson J, Russell IJ, Herbert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38:19–28
   PubMed Web of Science ®Google Scholar
• Martinez JE, Ferraz MB, Sato EI, Atra E. Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. J Rheumatol 1995; 22:270–4
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, Costa DD, Poyhia R. A study of standard care in fibromyalgia syndrome: a favourable outcome. J Rheumatol 2003; 30:154–9
   PubMed Web of Science ®Google Scholar
• Wolfe F, Anderson J, Harkness D, et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 1997; 40:1571–9
   PubMed Web of Science ®Google Scholar
• Ledingham J, Doherty S, Doherty M. Primary fibromyalgia - an outcome study. Br J Rheumatol 1993; 32:139–42
   PubMedGoogle Scholar
• Kalyan-Raman UP, Kalyan-Raman K, Yunus MB, Masi AT. Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol 1984; 11:808–13
   PubMed Web of Science ®Google Scholar
• Yunus MB, Kalyan-Raman UP, Masi AT, Aldag JC. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 1989; 16:97–101
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Henriksson KG, Larsson J. Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings Scand J Rheumatol 1986; 15:1–6
   PubMed Web of Science ®Google Scholar
• Bengtsson A. The muscle in fibromyalgia. Rheumatology 2002; 41:721–4
   PubMed Web of Science ®Google Scholar
• Drewes AM, Andreasen A, Schroder HD, Hogsaa B, Jennum P. Pathology of skeletal muscle in fibromyalgia: a histo-immuno- chemical and ultrastructural study. Br J Rheumatol 1993; 32:479–83
   PubMedGoogle Scholar
• Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986; 15:165–73
   PubMed Web of Science ®Google Scholar
• de Blecourt AC, Wolf RF, van Rijswijk MH, Kamman RL, Knipping AA, Mooyaart EL. In vivo 31P magnetic resonance spectroscopy (MRS) of tender points in patients with primary fibromyalgia syndrome. Rheumatol Int 1991; 11:51–4
   PubMed Web of Science ®Google Scholar
• Sprott H, Rzanny R, Reichenbach JR, Kaiser WA, Hein G, Stein G. 31P magnetic resonance spectroscopy in fibromyalgic muscle. Rheumatology2000;39:1121–5
   Google Scholar
• Simms RW. Fibromyalgia is not a muscle disorder. Am J Med Sci 1998; 315:346–50
   PubMed Web of Science ®Google Scholar
• 24* Crofford LJ. Neuroendocrine abnormalities in fibromyalgia and related disorders Am J Med Sci 1998;315:359–66
   Google Scholar
• Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53:865–71
   PubMed Web of Science ®Google Scholar
• Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20:469–74
   PubMed Web of Science ®Google Scholar
• Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): a clinical study of 50 patients with matched normal controls Semin Arthritis Rheum 1981;11:151–71
   Google Scholar
• Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106:534–43
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Casey KL. Central modulation of pain perception. Rheum Dis Clin North Am 1999; 25:1–13
   PubMed Web of Science ®Google Scholar
• Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 2000; 43:872–80
   PubMed Web of Science ®Google Scholar
• Geenen R, Jacobs JW, Bijlsma JW. Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 2002; 28:389–404
   PubMed Web of Science ®Google Scholar
• Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52:259–85
   PubMed Web of Science ®Google Scholar
• Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91:165–75
   PubMed Web of Science ®Google Scholar
• 34* Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999 4:385–98
   Google Scholar
• Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997; 40:1928–39
   PubMed Web of Science ®Google Scholar
• Bennett GJ. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage 2000; 19 (1 Suppl):S2-6
   PubMed Web of Science ®Google Scholar
• Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 1994; 37:1593–601
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988;32:21–6
   Google Scholar
• DeVane CL. Substance P: a new era, a new role. Pharmacotherapy 2001; 21:1061–9
   PubMed Web of Science ®Google Scholar
• 40* Russell IJ. Advances in fibromyalgia: possible role for central neurochemicals Am J Med Sci 1998;315:377–84
   Google Scholar
• Schwarz MJ, Spath M, Muller-Bardoff H, Pongratz DE, Bondy B, Ackenheil M. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett 1999; 259:196–8
   PubMed Web of Science ®Google Scholar
• Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA, Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992; 19:104–9
   PubMed Web of Science ®Google Scholar
• Li J, Simone DA, Larson AA. Windup leads to characteristics of central sensitisation. Pain 1999; 79:75–82
   PubMed Web of Science ®Google Scholar